Mario Gabelli's CGTX Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 20,000 shares of Cognition Therapeutics, Inc. (CGTX) worth $23,000, representing 0.00% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Mario Gabelli has maintained this position in CGTX for several quarters, showing initial confidence in the investment.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Cognition Therapeutics (CGTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cognition Therapeutics (CGTX) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +20,000 | New Buy | 20,000 | $1.35 |
Mario Gabelli's Cognition Therapeutics Investment FAQs
Mario Gabelli first purchased Cognition Therapeutics, Inc. (CGTX) in Q3 2025, acquiring 20,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Cognition Therapeutics, Inc. (CGTX) for 4 quarters since Q3 2025.
Mario Gabelli's largest addition to Cognition Therapeutics, Inc. (CGTX) was in Q3 2025, adding 20,000 shares worth $27,000.
According to the latest 13F filing for Q2 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 20,000 shares of Cognition Therapeutics, Inc. (CGTX), valued at approximately $23,000.
As of the Q2 2026 filing, Cognition Therapeutics, Inc. (CGTX) represents approximately 0.00% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Cognition Therapeutics, Inc. (CGTX) was 20,000 shares, as reported at the end of Q3 2025.